Published in Blood on September 18, 2008
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci (2011) 5.42
Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 3.02
Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol (2010) 1.43
Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost (2011) 1.43
Extracellular vesicles: emerging targets for cancer therapy. Trends Mol Med (2014) 1.35
Circulating microparticles: square the circle. BMC Cell Biol (2013) 1.14
C. elegans ciliated sensory neurons release extracellular vesicles that function in animal communication. Curr Biol (2014) 1.11
Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost (2009) 1.08
Isolation and characterization of platelet-derived extracellular vesicles. J Extracell Vesicles (2014) 1.07
Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets. Mol Pharmacol (2013) 0.93
Cells in dengue virus infection in vivo. Adv Virol (2010) 0.90
Microparticle analysis in disorders of hemostasis and thrombosis. Cytometry A (2015) 0.89
CLEC-2 expression is maintained on activated platelets and on platelet microparticles. Blood (2014) 0.89
Shear enhances thrombopoiesis and formation of microparticles that induce megakaryocytic differentiation of stem cells. Blood (2014) 0.89
The role of platelets in the recruitment of leukocytes during vascular disease. Platelets (2015) 0.87
Microvesicles as potential ovarian cancer biomarkers. Biomed Res Int (2013) 0.86
Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet production. Blood (2011) 0.84
Multipotent role of platelets in inflammatory bowel diseases: a clinical approach. World J Gastroenterol (2014) 0.83
Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler syndrome. Proc Natl Acad Sci U S A (2014) 0.82
A novel method for overexpression of peroxisome proliferator-activated receptor-γ in megakaryocyte and platelet microparticles achieves transcellular signaling. J Thromb Haemost (2012) 0.82
Microparticles: a new perspective in central nervous system disorders. Biomed Res Int (2014) 0.82
Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots. Sci Rep (2015) 0.82
Microparticles That Form Immune Complexes as Modulatory Structures in Autoimmune Responses. Mediators Inflamm (2015) 0.77
Megakaryocyte-derived microvesicles, please stand up! Blood (2009) 0.76
Microparticles engineered to highly express peroxisome proliferator-activated receptor-γ decreased inflammatory mediator production and increased adhesion of recipient monocytes. PLoS One (2014) 0.76
Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm. Prz Menopauzalny (2015) 0.76
Thrombocytogenesis by megakaryocyte; Interpretation by protoplatelet hypothesis. Proc Jpn Acad Ser B Phys Biol Sci (2011) 0.76
Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis. Front Pharmacol (2016) 0.76
The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression. Tumour Biol (2016) 0.75
Phospholipid Binding Protein C Inhibitor (PCI) Is Present on Microparticles Generated In Vitro and In Vivo. PLoS One (2015) 0.75
Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases. Semin Thromb Hemost (2014) 0.75
Revealing the diversity of extracellular vesicles using high-dimensional flow cytometry analyses. Sci Rep (2016) 0.75
Distinct features of circulating microparticles and their relationship with disease activity in inflammatory bowel disease. Ann Gastroenterol (2016) 0.75
Platelet-derived microvesicles are involved in cardio-protective effects of remote preconditioning. Int J Clin Exp Pathol (2015) 0.75
Megakaryocytes compensate for Kit insufficiency in murine arthritis. J Clin Invest (2017) 0.75
The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles. J Biol Chem (2016) 0.75
Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia. Haematologica (2016) 0.75
Distinct proteome pathology of circulating microparticles in systemic lupus erythematosus. Clin Proteomics (2017) 0.75
New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus. Curr Rheumatol Rep (2017) 0.75
Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood (2007) 4.73
Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med (2003) 4.69
Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell (2000) 4.45
Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol (1999) 3.26
The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) (2005) 3.24
Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation (2000) 3.08
Thrombogenesis in sickle cell disease. J Lab Clin Med (2001) 2.75
Platelet formation is the consequence of caspase activation within megakaryocytes. Blood (2002) 2.62
Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol (2004) 2.42
Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost (2001) 2.38
The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest (2005) 2.30
Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS (2003) 2.12
Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood (1995) 1.94
In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A (1996) 1.90
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood (1994) 1.90
Platelet activation leads to activation and propagation of the complement system. J Exp Med (2005) 1.76
Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytes. Blood (2005) 1.76
Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost (2001) 1.65
A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets. Curr Biol (2001) 1.54
Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol (1999) 1.50
Blood platelet formation in vitro. The role of the cytoskeleton in megakaryocyte fragmentation. J Cell Sci (1990) 1.49
Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A (2007) 1.48
Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood (2002) 1.41
Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood (1997) 1.33
Loss of PIP5KIgamma, unlike other PIP5KI isoforms, impairs the integrity of the membrane cytoskeleton in murine megakaryocytes. J Clin Invest (2008) 1.33
Platelet microparticles induce angiogenesis in vitro. Br J Haematol (2004) 1.28
Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res (1993) 1.27
Moesin, the major ERM protein of lymphocytes and platelets, differs from ezrin in its insensitivity to calpain. FEBS Lett (1999) 1.24
The demarcation membrane system of the megakaryocyte: a misnomer? Blood (1982) 1.21
Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem (1991) 1.13
P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem (2006) 1.13
Formation and fate of platelet microparticles. Blood Cells Mol Dis (2006) 1.10
Induction of platelet formation from megakaryocytoid cells by nitric oxide. Proc Natl Acad Sci U S A (2001) 1.08
Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost (2006) 1.06
Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. Biochemistry (1995) 1.05
Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry (1990) 1.04
Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem (1996) 1.02
Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. J Cell Biol (1990) 1.01
Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood (2000) 1.00
Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes. Blood (2006) 0.99
Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. Kidney Int (2002) 0.98
The potential role of platelet microparticles in atherosclerosis. Thromb Haemost (2005) 0.97
In vitro platelet release by rat megakaryocytes: effect of metabolic inhibitors and cytoskeletal disrupting agents. Am J Vet Res (1987) 0.96
Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen. Biochem J (1998) 0.93
Expression of complement components and inhibitors on platelet microparticles. Platelets (2008) 0.92
Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. Blood (1991) 0.91
A bleeding disorder characterised by isolated deficiency of platelet microvesicle generation. Lancet (1996) 0.91
Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol (1997) 0.91
Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. J Biol Chem (1993) 0.91
Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Haemost (1996) 0.88
Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation? Biochim Biophys Acta (1994) 0.85
Flow cytometric analysis of material-induced platelet activation in a canine model: elevated microparticle levels and reduced platelet life span. J Biomed Mater Res (1997) 0.82
Phosphatidylinositol 4,5-bisphosphate regulates activation-induced platelet microparticle formation. Biochemistry (2005) 0.82
Relationship of microparticles with beta 2-glycoprotein I and P-selectin positivity to anticardiolipin antibodies in immune thrombocytopenic purpura. Ann Hematol (1995) 0.79
Purification of mammalian filamin. Similarity to high molecular weight actin-binding protein in macrophages, platelets, fibroblasts, and other tissues. J Biol Chem (1978) 0.78
Dynamic visualization of thrombopoiesis within bone marrow. Science (2007) 4.35
Platelets and the immune continuum. Nat Rev Immunol (2011) 4.18
Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood (2007) 3.38
Platelets actively sequester angiogenesis regulators. Blood (2008) 2.47
The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest (2005) 2.30
Visualization of microtubule growth in living platelets reveals a dynamic marginal band with multiple microtubules. Blood (2008) 2.20
Cytoskeletal mechanics of proplatelet maturation and platelet release. J Cell Biol (2010) 2.18
Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo. Blood (2009) 2.00
Platelet bioreactor-on-a-chip. Blood (2014) 1.87
Identification of the first human gyrovirus, a virus related to chicken anemia virus. J Virol (2011) 1.81
Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood (2010) 1.81
Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytes. Blood (2005) 1.76
High-content live-cell imaging assay used to establish mechanism of trastuzumab emtansine (T-DM1)--mediated inhibition of platelet production. Blood (2012) 1.73
The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol (2013) 1.67
The spectrin-based membrane skeleton stabilizes mouse megakaryocyte membrane systems and is essential for proplatelet and platelet formation. Blood (2011) 1.67
Serum response factor is an essential transcription factor in megakaryocytic maturation. Blood (2010) 1.65
Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood (2011) 1.64
A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site. Blood (2012) 1.59
Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation. Arterioscler Thromb Vasc Biol (2007) 1.56
The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models. Genome Biol (2013) 1.54
Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res (2011) 1.48
Mechanisms of organelle transport and capture along proplatelets during platelet production. Blood (2005) 1.47
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. J Clin Invest (2012) 1.45
Human polyomavirus related to African green monkey lymphotropic polyomavirus. Emerg Infect Dis (2011) 1.36
ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells. J Biol Chem (2008) 1.34
Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. J Bone Miner Res (2004) 1.33
Platelet-associated PF-4 as a biomarker of early tumor growth. Blood (2007) 1.26
Alpha-adducin dissociates from F-actin and spectrin during platelet activation. J Cell Biol (2003) 1.25
Microtubule and cortical forces determine platelet size during vascular platelet production. Nat Commun (2012) 1.24
Importance of free actin filament barbed ends for Arp2/3 complex function in platelets and fibroblasts. Proc Natl Acad Sci U S A (2002) 1.23
Epidemiology, molecular virology and diagnostics of Schmallenberg virus, an emerging orthobunyavirus in Europe. Vet Res (2013) 1.20
The actin cytoskeleton differentially regulates platelet alpha-granule and dense-granule secretion. Blood (2005) 1.16
T granules in human platelets function in TLR9 organization and signaling. J Cell Biol (2012) 1.13
Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation. Br J Haematol (2014) 1.12
VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis (2012) 1.12
Platelet formation. Semin Hematol (2010) 1.12
A role for Rab27b in NF-E2-dependent pathways of platelet formation. Blood (2003) 1.11
Identification of an antithrombotic allosteric modulator that acts through helix 8 of PAR1. Proc Natl Acad Sci U S A (2011) 1.11
Delivering new insight into the biology of megakaryopoiesis and thrombopoiesis. Curr Opin Hematol (2007) 1.09
Cytoskeletal mechanisms for platelet production. Blood Cells Mol Dis (2006) 1.08
Does size matter in platelet production? Blood (2012) 1.07
Junín virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling. PLoS Pathog (2010) 1.07
Platelets: production, morphology and ultrastructure. Handb Exp Pharmacol (2012) 1.06
RanBP10 is a cytoplasmic guanine nucleotide exchange factor that modulates noncentrosomal microtubules. J Biol Chem (2008) 1.06
Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein. J Biol Chem (2012) 1.05
The origin and function of platelet glycosyltransferases. Blood (2012) 1.04
Normal ranges of angiogenesis regulatory proteins in human platelets. Am J Hematol (2010) 1.02
Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics (2009) 1.01
Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response. Blood (2013) 0.97
MKL1 and MKL2 play redundant and crucial roles in megakaryocyte maturation and platelet formation. Blood (2012) 0.96
Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems. Vaccine (2008) 0.95
Glucocorticoid receptor is required for foetal heart maturation. Hum Mol Genet (2013) 0.95
Direct visualization of the endomitotic cell cycle in living megakaryocytes: differential patterns in low and high ploidy cells. Cell Cycle (2008) 0.95
Discovery of 1,3-Diaminobenzenes as Selective Inhibitors of Platelet Activation at the PAR1 Receptor. ACS Med Chem Lett (2012) 0.94
Proteasome function is required for platelet production. J Clin Invest (2014) 0.93
The platelet actin cytoskeleton associates with SNAREs and participates in alpha-granule secretion. Biochemistry (2010) 0.92
Dynamin-related protein-1 controls fusion pore dynamics during platelet granule exocytosis. Arterioscler Thromb Vasc Biol (2013) 0.91
Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Semin Perinatol (2009) 0.91
Composition of bacillus species in aerosols from 11 U.S. cities. J Forensic Sci (2006) 0.90
Neonatal and adult megakaryopoiesis. Curr Opin Hematol (2011) 0.89
Visualization and manipulation of the platelet and megakaryocyte cytoskeleton. Methods Mol Biol (2012) 0.89
Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors. J Gen Virol (2006) 0.89
Borna disease virus infects human neural progenitor cells and impairs neurogenesis. J Virol (2011) 0.88
Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice. Transfusion (2013) 0.87
Macrocytic anemia and mitochondriopathy resulting from a defect in sideroflexin 4. Am J Hum Genet (2013) 0.86
Zebrafish have a competent p53-dependent nucleotide excision repair pathway to resolve ultraviolet B-induced DNA damage in the skin. Zebrafish (2009) 0.86
Umbilical cord blood produces small megakaryocytes after transplantation. Biol Blood Marrow Transplant (2007) 0.85
Closure times measured by the platelet function analyzer PFA-100 are longer in neonatal blood compared to cord blood samples. Neonatology (2009) 0.85
Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cells. J Clin Invest (2015) 0.85
Disulfide bond formation in NGR fiber-modified adenovirus is essential for retargeting to aminopeptidase N. Biochem Biophys Res Commun (2006) 0.84
Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep. Vaccine (2010) 0.84
Canonical Wnt signaling in megakaryocytes regulates proplatelet formation. Blood (2012) 0.84
Platelet- and megakaryocyte-derived microparticles. Semin Thromb Hemost (2010) 0.83
Proplatelet generation in the mouse requires PKCε-dependent RhoA inhibition. Blood (2013) 0.82
Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland. Transfusion (2011) 0.82
Fluorescent heteroduplex assay for monitoring Bacillus anthracis and close relatives in environmental samples. Appl Environ Microbiol (2003) 0.81
Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow. J Pediatr Hematol Oncol (2008) 0.81
Neonatal thrombocytopenia and megakaryocytopoiesis. Semin Hematol (2010) 0.80
Vaccination against the feline immunodeficiency virus: the road not taken. Comp Immunol Microbiol Infect Dis (2007) 0.80
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice. Thromb Haemost (2015) 0.80
Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset. Vaccine (2011) 0.79
The disulfide bond of an RGD4C motif inserted within the Hi loop of the adenovirus type 5 fiber protein is critical for retargeting to αv -integrins. J Gene Med (2012) 0.79
Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties. J Gen Virol (2005) 0.79
The microtubule plus-end tracking protein CLASP2 is required for hematopoiesis and hematopoietic stem cell maintenance. Cell Rep (2012) 0.79
Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS. Vaccine (2008) 0.79
Altered microtubule equilibrium and impaired thrombus stability in mice lacking RanBP10. Blood (2012) 0.78
Role for phosphoinositide 3-kinase in Fc gamma RIIA-induced platelet shape change. Am J Physiol Cell Physiol (2003) 0.78
Clinical and research issues in neonatal anemia and thrombocytopenia. Curr Opin Pediatr (2012) 0.78
Correction for effect of cold storage on immature platelet fraction. J Clin Lab Anal (2010) 0.78
Differential role of alpha(v)beta(3) and alpha(v)beta(5) integrins in internalization and transduction efficacies of wild type and RGD4C fiber-modified adenoviruses. Virus Res (2008) 0.78
A zebrafish model for nevus regeneration. Pigment Cell Melanoma Res (2011) 0.78